52
Participants
Start Date
May 20, 2025
Primary Completion Date
September 30, 2025
Study Completion Date
October 10, 2025
Non-steroidal anti-inflammatory drugs (NSAID)
The participants will receive non-steroidal anti- inflammatory drugs (NSAID), Diclofenac 20 mg/ day for 3 consecutive menstrual cycles.
Transcutaneous Electrical Acupoint Stimulation (TEAS)
"The participants will receive transcutaneous electrical acupoint Stimulation (TEAS). These acupoints will include large intestine 14 (LI4) , gall bladder 34 (GB34), large intestine 11 (LI11), Gall bladder 39 (GB39) and stomach 36 (ST 36). The session will be applied for 30 minutes / 3 days/ week, in addition to Diclofenac 20 mg/ day for 3 consecutive menstrual cycles.~."
Lamiaa Mostafa Okeil, Al Fayyum
Cairo University
OTHER